Difference between revisions of "Actin (TG2)"
m (Actin moved to Actin (TG2)) |
m |
||
| Line 37: | Line 37: | ||
| Surface accessibility | | Surface accessibility | ||
| [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] (pdf) | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] (pdf) | ||
| + | [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.txt ASAView] (txt) | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 07:05, 25 July 2007
| Template:Infobox header| Actin (TG2) | |
|---|---|
| Actin (TG2) | |
| Substrate peptide name | Actin (TG2) |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cytoskeleton |
| Swissprot ID | P08865 |
| Reactive glutamines | Q41 |
| Reactive lysines | K113 |
| Substrate sequence | GRPRHQGVMVG
APLNPKANREK |
| Structure | 2BTF |
| Surface accessibility | ASAView (pdf)
ASAView (txt) |
| Disorder prediction | IUPred |
| Reference | PMID:9252372 |
| Notes | |
| Template:Infobox header | | |
.png){kind=link}